AstraZeneca files $39 billion acquisition of Alexion Pharmaceuticals for EU review
Drugmaker AstraZeneca has requested EU approval to buy US rival Alexion Pharmaceuticals, according to an update today on the European Commission's register of deals. The commission has set a July 5...To view the full article, register now.
Already a subscriber? Click here to view full article